Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1970 1
1972 1
1973 1
1974 1
1975 3
1976 1
1977 2
1979 2
1980 3
1981 3
1982 3
1984 10
1985 47
1986 57
1987 90
1988 84
1989 113
1990 163
1991 157
1992 163
1993 177
1994 189
1995 223
1996 291
1997 305
1998 263
1999 376
2000 403
2001 444
2002 517
2003 579
2004 717
2005 818
2006 1063
2007 1096
2008 1165
2009 1327
2010 1551
2011 1869
2012 2085
2013 2408
2014 2683
2015 3310
2016 3547
2017 4127
2018 4743
2019 5396
2020 6419
2021 6987
2022 7533
2023 7366
2024 8153
2025 884

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71,392 results

Results by year

Filters applied: . Clear all
Page 1
Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.
Zou Y, Xie J, Zheng S, Liu W, Tang Y, Tian W, Deng X, Wu L, Zhang Y, Wong CW, Tan D, Liu Q, Xie X. Zou Y, et al. Int J Surg. 2022 Nov;107:106936. doi: 10.1016/j.ijsu.2022.106936. Epub 2022 Sep 20. Int J Surg. 2022. PMID: 36341760
BACKGROUND: Postoperative progression and chemotherapy resistance is the major cause of treatment failure in patients with triple-negative breast cancer (TNBC). ...Validated in five independent datasets, TNBC patients with high CDI had a worse prognosi …
BACKGROUND: Postoperative progression and chemotherapy resistance is the major cause of treatment failure in patients with tri …
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.
Nedeljković M, Damjanović A. Nedeljković M, et al. Cells. 2019 Aug 22;8(9):957. doi: 10.3390/cells8090957. Cells. 2019. PMID: 31443516 Free PMC article. Review.
Triple-negative (TNBC) is the most lethal subtype of breast cancer owing to high heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the standard of care for TNBC treatment, but unfortunately, patients frequently develop resistance. …
Triple-negative (TNBC) is the most lethal subtype of breast cancer owing to high heterogeneity, aggressive nature, and lack of treatm …
Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
Kim M, Lee JS, Kim W, Lee JH, Jun BH, Kim KS, Kim DE. Kim M, et al. J Control Release. 2022 Aug;348:893-910. doi: 10.1016/j.jconrel.2022.06.039. Epub 2022 Jun 29. J Control Release. 2022. PMID: 35760233
To reverse immunosuppressive TME and reactivate immune response, cancer-targeting nano-liposomes were prepared to contain immunogenic cell death inducer (Doxorubicin, DOX) and IDO1 siRNA, namely Aptm[DOX/IDO1]. The Aptm[DOX/IDO1] specifically delivered the loaded DO …
To reverse immunosuppressive TME and reactivate immune response, cancer-targeting nano-liposomes were prepared to contain immu …
Theranostic Near-Infrared-Active Conjugated Polymer Nanoparticles.
Zhao M, Leggett E, Bourke S, Poursanidou S, Carter-Searjeant S, Po S, Palma do Carmo M, Dailey LA, Manning P, Ryan SG, Urbano L, Green MA, Rakovich A. Zhao M, et al. ACS Nano. 2021 May 25;15(5):8790-8802. doi: 10.1021/acsnano.1c01257. Epub 2021 May 12. ACS Nano. 2021. PMID: 33978405
Conjugated polymer nanoparticles (CPNs) based on a common solar cell material (PTB7) have been prepared, and their potential in theranostic applications based on bioimaging and photosensitizing capabilities has been evaluated. ...
Conjugated polymer nanoparticles (CPNs) based on a common solar cell material (PTB7) have been prepared, and their pote …
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, Sikirzhytski V, Tokat UM, Aykut G, Ansari SA, Dogan HT, Dogan M, Jandaghi P, Isik A, Gundogdu F, Kosemehmetoglu K, Dizdar O, Aksoy S, Akyol A, Uner A, Buckhaults PJ, Riazalhosseini Y, Sahin O. Saatci O, et al. Nat Commun. 2020 May 15;11(1):2416. doi: 10.1038/s41467-020-16199-4. Nat Commun. 2020. PMID: 32415208 Free PMC article.
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Here we identify hypoxia-induced ECM re-modeler, lysyl oxidase (LOX) as a key inducer of chemoresistance by developing chemoresistant TNBC tumors …
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Here we ident …
Conjugated polymer nanoparticles.
Tuncel D, Demir HV. Tuncel D, et al. Nanoscale. 2010 Apr;2(4):484-94. doi: 10.1039/b9nr00374f. Epub 2010 Mar 6. Nanoscale. 2010. PMID: 20644748 Review.
Conjugated polymer nanoparticles are highly versatile nano-structured materials that can potentially find applications in various areas such as optoelectronics, photonics, bio-imaging, bio-sensing and nanomedicine. ...
Conjugated polymer nanoparticles are highly versatile nano-structured materials that can potentially find applications …
pi-Conjugated Polymer Nanoparticles from Design, Synthesis to Biomedical Applications: Sensing, Imaging, and Therapy.
Elgiddawy N, Elnagar N, Korri-Youssoufi H, Yassar A. Elgiddawy N, et al. Microorganisms. 2023 Aug 3;11(8):2006. doi: 10.3390/microorganisms11082006. Microorganisms. 2023. PMID: 37630566 Free PMC article. Review.
In the past decade, pi-conjugated polymer nanoparticles (CPNs) have been considered as promising nanomaterials for biomedical applications, and are widely used as probe materials for bioimaging and drug delivery. ...
In the past decade, pi-conjugated polymer nanoparticles (CPNs) have been considered as promising nanomaterials for biom …
Aptamer photoregulation in vivo.
Li L, Tong R, Chu H, Wang W, Langer R, Kohane DS. Li L, et al. Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17099-103. doi: 10.1073/pnas.1420105111. Epub 2014 Nov 17. Proc Natl Acad Sci U S A. 2014. PMID: 25404344 Free PMC article.
We designed a light-triggered system that permits spatiotemporal regulation of aptamer activity in vitro and in vivo. Cell binding by the aptamer was prevented by hybridizing the aptamer to a photo-labile complementary oligonucleotide. Upon irradiation at the …
We designed a light-triggered system that permits spatiotemporal regulation of aptamer activity in vitro and in vivo. Cell binding by …
Trojan horse monocyte-mediated delivery of conjugated polymer nanoparticles for improved photodynamic therapy of glioblastoma.
Ibarra LE, Beaugé L, Arias-Ramos N, Rivarola VA, Chesta CA, López-Larrubia P, Palacios RE. Ibarra LE, et al. Nanomedicine (Lond). 2020 Jul;15(17):1687-1707. doi: 10.2217/nnm-2020-0106. Epub 2020 Jul 21. Nanomedicine (Lond). 2020. PMID: 32689873 Free article.
Aim: To assess monocyte-based delivery of conjugated polymer nanoparticles (CPNs) for improved photodynamic therapy (PDT) in glioblastoma (GBM). ...
Aim: To assess monocyte-based delivery of conjugated polymer nanoparticles (CPNs) for improved photodynamic t …
How promising is phototherapy for cancer?
Shi H, Sadler PJ. Shi H, et al. Br J Cancer. 2020 Sep;123(6):871-873. doi: 10.1038/s41416-020-0926-3. Epub 2020 Jun 26. Br J Cancer. 2020. PMID: 32587359 Free PMC article.
Oncological phototherapy, including current photodynamic therapy (PDT), developmental photoactivated chemotherapy (PACT) and photothermal therapy (PTT), shows promising photo-efficacy for superficial and internal tumours. The dual application of light and photochemo …
Oncological phototherapy, including current photodynamic therapy (PDT), developmental photoactivated chemotherapy (PACT) and p …
71,392 results
You have reached the last available page of results. Please see the User Guide for more information.